These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 4974382)

  • 1. Mechanism of tuberculostasis in mammalian serum. II. Induction of serum tuberculostasis in guinea pigs.
    Kochan I; Golden CA; Bukovic JA
    J Bacteriol; 1969 Oct; 100(1):64-70. PubMed ID: 4899010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung weight parallels disease severity in experimental coccidioidomycosis.
    Huppert M; Sun SH; Gleason-Jordon I; Vukovich KR
    Infect Immun; 1976 Dec; 14(6):1356-68. PubMed ID: 1002301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.
    Youmans AS; Youmans GP; Cahall D
    Infect Immun; 1976 Jan; 13(1):127-32. PubMed ID: 814098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunizing capacity of viable and killed attenuated mycobacterial cells against experimental tuberculous infection.
    Youmans GP; Youmans AS
    J Bacteriol; 1969 Jan; 97(1):107-13. PubMed ID: 4974382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.
    Coppel S; Youmans GP
    J Bacteriol; 1969 Jan; 97(1):114-20. PubMed ID: 4974383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations.
    Neiburger RG; Youmans GP; Youmans AS
    Infect Immun; 1973 Jul; 8(1):42-7. PubMed ID: 4198103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
    Hwang SA; Kruzel ML; Actor JK
    Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculous immunity in mice vaccinated with killed tubercle bacilli.
    DUBOS RJ; SCHAEFER WB; PIERCE CH
    J Exp Med; 1953 Feb; 97(2):221-33. PubMed ID: 13022875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of Acquired Resistance Produced by Immunization with Listeria monocytogenes and Listeria Fractions.
    Coppel S; Youmans GP
    J Bacteriol; 1969 Jan; 97(1):121-6. PubMed ID: 16562159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.
    YOUMANS AS; YOUMANS GP
    J Bacteriol; 1965 May; 89(5):1291-8. PubMed ID: 14293000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE EFFECT OF ADJUVANTS ON A NONVIABLE ANTITUBERCULOSIS VACCINE AND ON LIVE BCG.
    HOYT A; THOMPSON MA; MOORE FJ; SMITH CR
    Am Rev Respir Dis; 1965 Apr; 91():565-74. PubMed ID: 14263935
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.